The American Medical
Association (AMA) has called
for a ban on direct-to-consumer
(DTC) advertising for medications
and medical devices because
of the negative impact of the
commercially driven promotions.
“The United States and New
Zealand are the only two countries
in the world that allow directto-
consumer advertising of
prescription drugs,” the AMA said
in a statement, with advertising
dollars spent by drug makers up
30% in the last two years to a
whopping US$4.5 billion.
The Association says the
advertising creates demand for
newer, more expensive treatments
event though less costly options
may be available.The above article was sent to subscribers in Pharmacy Daily's issue from 20 Nov 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Nov 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.